Maxime Guye Selected Research

Maxime Guye Research Topics

5	Epilepsy (Aura) 01/2021 - 02/2010
4	Multiple Sclerosis 10/2022 - 02/2014
4	Atrophy 01/2021 - 01/2017
4	Partial Epilepsies (Epilepsy, Partial) 01/2020 - 08/2010
3	Neoplasms (Cancer) 02/2017 - 02/2010
3	Temporal Lobe Epilepsy 09/2008 - 10/2002
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2018
2	Glioma (Gliomas) 02/2017 - 02/2015
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Drug Resistant Epilepsy 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Dementia (Dementias) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Sleep Deprivation 01/2018
1	Inflammation (Inflammations) 08/2017
1	Relapsing-Remitting Multiple Sclerosis 01/2017
1	Cognitive Dysfunction 01/2017
1	Sudden Unexpected Death in Epilepsy 01/2017
1	Disease Progression 01/2017
1	Seizures (Absence Seizure) 01/2017
1	Apraxias (Dyspraxia) 01/2016
1	Paraganglioma (Paragangliomas) 08/2015
1	Idiopathic Generalized Epilepsy 08/2009
1	Periventricular Nodular Heterotopia 01/2008

7	SodiumIBA 10/2022 - 02/2014
5	Pharmaceutical PreparationsIBA 01/2021 - 09/2008
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
4	trans-sodium crocetinate (crocetin)IBA 01/2019 - 01/2017
2	Choline (Choline Chloride)IBA 02/2015 - 02/2010
2	N-acetylaspartate (N-acetyl aspartate)IBA 02/2015 - 02/2010
2	CreatineIBA 02/2015 - 02/2010
1	Memantine (Namenda)FDA Link 01/2018
1	Donepezil (Aricept)FDA LinkGeneric 01/2018
1	GadoliniumIBA 02/2017
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2016
1	ferric oxide (iron oxide)IBA 01/2016
1	Tricarboxylic AcidsIBA 08/2015
1	Succinic Acid (Succinate)IBA 08/2015
1	Oxygen (Dioxygen)IBA 08/2010
1	Immunoglobulin E (IgE)IBA 08/2009
1	Complement System Proteins (Complement)IBA 03/2006
1	Protons (Proton)IBA 10/2002

3	Electrodes (Electrode) 01/2019 - 10/2002
1	Craniotomy 02/2017
1	Split-Brain Procedure (Split-Brain) 01/2016
1	Therapeutics 08/2015